DE69223971T2 - Kolorimetrische Bestimmung von Magnesiumionen in Flüssigkeiten - Google Patents
Kolorimetrische Bestimmung von Magnesiumionen in FlüssigkeitenInfo
- Publication number
- DE69223971T2 DE69223971T2 DE69223971T DE69223971T DE69223971T2 DE 69223971 T2 DE69223971 T2 DE 69223971T2 DE 69223971 T DE69223971 T DE 69223971T DE 69223971 T DE69223971 T DE 69223971T DE 69223971 T2 DE69223971 T2 DE 69223971T2
- Authority
- DE
- Germany
- Prior art keywords
- reagent
- magnesium
- complexing agent
- detergent
- ions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 title claims description 29
- 229910001425 magnesium ion Inorganic materials 0.000 title claims description 29
- 239000007788 liquid Substances 0.000 title description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims description 61
- 238000000034 method Methods 0.000 claims description 36
- 239000012530 fluid Substances 0.000 claims description 24
- 239000008139 complexing agent Substances 0.000 claims description 16
- 239000003599 detergent Substances 0.000 claims description 13
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 claims description 13
- 230000015572 biosynthetic process Effects 0.000 claims description 11
- NJZWLEZSGOTSHR-UHFFFAOYSA-N 3-[(2-arsonophenyl)diazenyl]-4,5-dihydroxynaphthalene-2,7-disulfonic acid Chemical compound OC1=C2C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=C1N=NC1=CC=CC=C1[As](O)(O)=O NJZWLEZSGOTSHR-UHFFFAOYSA-N 0.000 claims description 8
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 7
- 229910001424 calcium ion Inorganic materials 0.000 claims description 7
- 229910001427 strontium ion Inorganic materials 0.000 claims description 7
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 7
- FTEDXVNDVHYDQW-UHFFFAOYSA-N BAPTA Chemical compound OC(=O)CN(CC(O)=O)C1=CC=CC=C1OCCOC1=CC=CC=C1N(CC(O)=O)CC(O)=O FTEDXVNDVHYDQW-UHFFFAOYSA-N 0.000 claims description 6
- 230000002452 interceptive effect Effects 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 150000001768 cations Chemical class 0.000 claims description 5
- 230000031700 light absorption Effects 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 239000000872 buffer Substances 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- IEQAICDLOKRSRL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEQAICDLOKRSRL-UHFFFAOYSA-N 0.000 claims description 3
- 239000013504 Triton X-100 Substances 0.000 claims description 3
- 229920004890 Triton X-100 Polymers 0.000 claims description 3
- 229920004896 Triton X-405 Polymers 0.000 claims description 3
- 230000003381 solubilizing effect Effects 0.000 claims description 3
- 239000002985 plastic film Substances 0.000 claims description 2
- 229920006255 plastic film Polymers 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 26
- 239000000975 dye Substances 0.000 description 26
- 229910052749 magnesium Inorganic materials 0.000 description 26
- 239000011777 magnesium Substances 0.000 description 26
- 239000000523 sample Substances 0.000 description 17
- VBRNLOQCBCPPHL-UHFFFAOYSA-N calmagite Chemical compound CC1=CC=C(O)C(N=NC=2C3=CC=CC=C3C(=CC=2O)S(O)(=O)=O)=C1 VBRNLOQCBCPPHL-UHFFFAOYSA-N 0.000 description 11
- 210000002966 serum Anatomy 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 238000001479 atomic absorption spectroscopy Methods 0.000 description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 7
- 230000008033 biological extinction Effects 0.000 description 7
- 229910052791 calcium Inorganic materials 0.000 description 7
- 239000011575 calcium Substances 0.000 description 7
- 239000012482 calibration solution Substances 0.000 description 7
- 210000002381 plasma Anatomy 0.000 description 7
- 238000004737 colorimetric analysis Methods 0.000 description 5
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- 239000013060 biological fluid Substances 0.000 description 4
- LVKZSFMYNWRPJX-UHFFFAOYSA-N phenylarsonic acid Chemical compound O[As](O)(=O)C1=CC=CC=C1 LVKZSFMYNWRPJX-UHFFFAOYSA-N 0.000 description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- -1 blood transfusions Chemical compound 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010020669 Hypermagnesaemia Diseases 0.000 description 2
- 206010021027 Hypomagnesaemia Diseases 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- JSSROCUNTZVPCI-UHFFFAOYSA-N chembl2002567 Chemical compound CC1=CC(C)=CC=C1NC(=O)C1=CC2=CC=CC=C2C(N=NC=2C(=CC=CC=2)O)=C1O JSSROCUNTZVPCI-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- IGFHQQFPSIBGKE-UHFFFAOYSA-N 4-nonylphenol Chemical compound CCCCCCCCCC1=CC=C(O)C=C1 IGFHQQFPSIBGKE-UHFFFAOYSA-N 0.000 description 1
- 208000010444 Acidosis Diseases 0.000 description 1
- 208000009304 Acute Kidney Injury Diseases 0.000 description 1
- 206010001367 Adrenal insufficiency Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 201000002980 Hyperparathyroidism Diseases 0.000 description 1
- 208000008167 Magnesium Deficiency Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000033626 Renal failure acute Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000007950 acidosis Effects 0.000 description 1
- 208000026545 acidosis disease Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 201000011040 acute kidney failure Diseases 0.000 description 1
- 208000012998 acute renal failure Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- SXYCCJAPZKHOLS-UHFFFAOYSA-N chembl2008674 Chemical compound [O-][N+](=O)C1=CC=C2C(N=NC3=C4C=CC=CC4=CC=C3O)=C(O)C=C(S(O)(=O)=O)C2=C1 SXYCCJAPZKHOLS-UHFFFAOYSA-N 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000011863 diuretic therapy Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 239000008233 hard water Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000003284 homeostatic effect Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000004764 magnesium deficiency Nutrition 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000007430 reference method Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- LKSHJHJGLORTGD-UHFFFAOYSA-M sodium 3-[[3-[(2,4-dimethylphenyl)carbamoyl]-2-hydroxynaphthalen-1-yl]diazenyl]-4-hydroxybenzenesulfonate Chemical compound [Na+].CC1=C(C=CC(=C1)C)NC(=O)C=1C(=C(C2=CC=CC=C2C1)N=NC=1C=C(C=CC1O)S(=O)(=O)[O-])O LKSHJHJGLORTGD-UHFFFAOYSA-M 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- PWYYWQHXAPXYMF-UHFFFAOYSA-N strontium(2+) Chemical compound [Sr+2] PWYYWQHXAPXYMF-UHFFFAOYSA-N 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- DIZZDZCUMBBRSG-UHFFFAOYSA-J tetrasodium;2-[[5-[3-[3-[[bis(carboxylatomethyl)amino]methyl]-4-hydroxy-2-methyl-5-propan-2-ylphenyl]-1,1-dioxo-2,1$l^{6}-benzoxathiol-3-yl]-2-hydroxy-6-methyl-3-propan-2-ylphenyl]methyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CC1=C(O)C(C(C)C)=CC(C2(C3=CC=CC=C3S(=O)(=O)O2)C=2C(=C(CN(CC([O-])=O)CC([O-])=O)C(O)=C(C(C)C)C=2)C)=C1C DIZZDZCUMBBRSG-UHFFFAOYSA-J 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B29/00—Monoazo dyes prepared by diazotising and coupling
- C09B29/0003—Monoazo dyes prepared by diazotising and coupling from diazotized anilines
- C09B29/0007—Monoazo dyes prepared by diazotising and coupling from diazotized anilines containing acid groups, e.g. CO2H, SO3H, PO3H2, OSO3H, OPO2H2; Salts thereof
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B29/00—Monoazo dyes prepared by diazotising and coupling
- C09B29/10—Monoazo dyes prepared by diazotising and coupling from coupling components containing hydroxy as the only directing group
- C09B29/16—Naphthol-sulfonic acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
- G01N31/22—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Hematology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Inorganic Chemistry (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPK746691 | 1991-07-26 | ||
| PCT/AU1992/000359 WO1993003100A1 (en) | 1991-07-26 | 1992-07-16 | Colorimetric determination of magnesium ions in fluids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69223971D1 DE69223971D1 (de) | 1998-02-12 |
| DE69223971T2 true DE69223971T2 (de) | 1998-05-20 |
Family
ID=3775585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69223971T Expired - Fee Related DE69223971T2 (de) | 1991-07-26 | 1992-07-16 | Kolorimetrische Bestimmung von Magnesiumionen in Flüssigkeiten |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0597900B1 (enExample) |
| DE (1) | DE69223971T2 (enExample) |
| ES (1) | ES2111075T3 (enExample) |
| GR (1) | GR3026257T3 (enExample) |
| WO (1) | WO1993003100A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10845346B2 (en) | 2015-05-29 | 2020-11-24 | Water Lens, LLC | Compositions, apparatus, and methods for determining hardness of water and magnesium ion in an analyte composition |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4166093A (en) * | 1977-08-08 | 1979-08-28 | Eastman Kodak Company | Reduction of detectable species migration in elements for the analysis of liquids |
| JPS58153166A (ja) * | 1982-03-08 | 1983-09-12 | Fujihira Kogyo Kk | マグネシウム定量用発色試薬 |
| US4871679A (en) * | 1986-07-15 | 1989-10-03 | Fuji Photo Film Co., Ltd. | Integral multilayer analytical element for determining calcium and its use |
| US5057435A (en) * | 1990-10-12 | 1991-10-15 | Synermed, Inc. | Reagent and methods for calcium determination |
-
1992
- 1992-07-16 ES ES92915842T patent/ES2111075T3/es not_active Expired - Lifetime
- 1992-07-16 EP EP92915842A patent/EP0597900B1/en not_active Expired - Lifetime
- 1992-07-16 WO PCT/AU1992/000359 patent/WO1993003100A1/en not_active Ceased
- 1992-07-16 DE DE69223971T patent/DE69223971T2/de not_active Expired - Fee Related
-
1998
- 1998-02-27 GR GR980400435T patent/GR3026257T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69223971D1 (de) | 1998-02-12 |
| EP0597900A1 (en) | 1994-05-25 |
| EP0597900B1 (en) | 1998-01-07 |
| GR3026257T3 (en) | 1998-05-29 |
| ES2111075T3 (es) | 1998-03-01 |
| WO1993003100A1 (en) | 1993-02-18 |
| EP0597900A4 (enExample) | 1994-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3876761T2 (de) | Denaturierende reagenzien zur bestimmung von haemoglobinderivaten im blut. | |
| DE69123519T2 (de) | Verfahren und Vorrichtung zur Bestimmung von Ionen | |
| DE2727730C2 (enExample) | ||
| DE69527947T2 (de) | Cyanidfreies reagens und verfahren zur bestimmung von hämoglobin | |
| DE68903884T2 (de) | Mittel und methode zur bestimmung von spurenmengen an proteinen. | |
| DE69731504T2 (de) | Reagenz und Verfahren zur Freisetzung und Bestimmung von Blei in biologischen Matrices | |
| DE68912218T2 (de) | Zusammensetzung und Verfahren zur Bestimmung spezifischer Gravitation von wässerigen Flüssigkeiten. | |
| DE69032422T2 (de) | Reagenzzusammensetzung, Verfahren und Kits zur Quantifizierung von Magnesium oder Calcium und Magnesium | |
| DE3852439T2 (de) | Reagenz zur Retikulozytenzählung mittels Durchfluss-zytometrie. | |
| DE2943423A1 (de) | Direktes verfahren zur bestimmung von eisen im blutserum | |
| DE2144136A1 (de) | Mittel und verfahren zur bestimmung von calcium | |
| EP0203334A2 (de) | Mittel und Verfahren zur Bestimmung von Calcium | |
| DE69111768T2 (de) | Enzymatische Zusammensetzung zur Bestimmung von Äthanol. | |
| EP0097472B1 (en) | Method of determining calcium in a fluid sample | |
| DE2533458A1 (de) | Verfahren und reagens zur bestimmung des gesamtcalciums in koerperfluessigkeiten | |
| EP0021245B1 (de) | Schnelltest zum Nachweis von Ascorbinsäure und Verfahren zu dessen Herstellung | |
| EP1340072B1 (de) | Verfahren und mittel zur bestimmung von gesamthärte | |
| EP0707210B1 (de) | Mittel und Verfahren zur Bestimmung von Ammoniumionen | |
| DE69223971T2 (de) | Kolorimetrische Bestimmung von Magnesiumionen in Flüssigkeiten | |
| DE69014512T2 (de) | Reagens zum Nachweis von Bilirubin in Urin. | |
| DE3806556A1 (de) | Verfahren und vorrichtung zur schnellen bestimmung der spermienanzahl in spermaproben und/oder des anteiles der lebenden spermien sowie verwendung von propidiumjodid | |
| Devoy et al. | Validation of a standardised method for determining beryllium in human urine at nanogram level | |
| DE3781007T2 (de) | Verfahren zur messung von phenol und alpha-naphthol, sowie ein verfahren zur messung der aktivitaet von enzymen. | |
| EP1188055B1 (de) | Labormässige untersuchung einer körperflüssigkeits- oder gewebeprobe | |
| AU662162B2 (en) | Colorimetric determination of magnesium ions in fluids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |